Angela Angjelova

Angela Angjelova

Faculty of Dentistry, Saints Cyril and Methodius University of Skopje, Skopje, North Macedonia
orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
AAAngela Angjelova
Angela Angjelova
EJElena Jovanova
Elena Jovanova
Alessandro PolizziAlessandro Polizzi
Alessandro Polizzi
LLLudovica Laganà
Ludovica Laganà
SSSimona Santonocito
Simona Santonocito
Gaetano IsolaGaetano Isola
Gaetano Isola
Periodontitis is a multifactorial chronic inflammatory disease that affects the periodontium and overall oral health and is primarily caused by a dysbiotic gingival biofilm, which includes, among others, Gram-negative bacteria such as Porphyromonas gingivalis, Actinobacillus actinomycetemcomitans, and Tannerella forsythensis that colonize gingival tissues and that can lead, if not properly treated, to periodontal tissue destruction and tooth loss. In the last few decades, several large-scale epidemiological studies have evidenced that mild and severe forms of periodontitis are strictly bilaterally associated with several cardiovascular diseases (CVDs), stroke, and endothelial dysfunction. Specifically, it is hypothesized that patients with severe periodontitis would have compromised endothelial function, a crucial step in the pathophysiology of atherosclerosis and several CVD forms. In this regard, it was postulated that periodontal treatment would ameliorate endothelial dysfunction, hence bolstering the notion that therapeutic approaches targeted at diminishing cardiovascular risk factors and different forms of periodontal treatment could improve several CVD biomarker outcomes in the short- and long-term in CVD patients. The aim of this review is to update and analyze the link between periodontitis and CVD, focusing on the inflammatory nature of periodontitis and its correlation with CVD, the effects of periodontal therapy on endothelial dysfunction and oxidative stress, and the impact of such therapy on CVD biomarkers and outcomes. The article also discusses future research directions in this field.

7 November 2025 in Journal of Periodontology
Verified
Journal Article
Open access
Gaetano IsolaGaetano Isola
Gaetano Isola
Marco AnnunziataMarco Annunziata
Marco Annunziata
AAAngela Angjelova
Angela Angjelova
AAAngela Alibrandi
Angela Alibrandi
Gianluca TartagliaGianluca Tartaglia
Gianluca Tartaglia
FSFrank A. Scannapieco
Frank A. Scannapieco
Background: A randomized, controlled trial was conducted to evaluate the effectiveness of two supportive periodontal care (SPC) approaches in patients with periodontitis and to evaluate possible predictors influencing bleeding on probing (BoP) changes at 24‐month follow‐up. Methods: Fifty‐six periodontitis patients who first received active periodontal treatment by means of quadrant‐wise subgingival instrumentation were subsequently assigned to either a control group (oral hygiene instruction with supragingival instrumentation and dental polishing, n = 28) or a test group (oral hygiene instruction with both supra‐ and subgingival instrumentation and dental polishing, n = 28). BoP was the primary outcome, and probing pocket depth (PPD), clinical attachment level (CAL), full‐mouth plaque score (FMPS), gingival bleeding index (GBI), and the number of pocket sites were secondary outcome measures, recorded up to 24 months of follow‐up. A mixed generalized linear regression analysis also assessed the potential confounding factors that influenced BoP changes at 24 months. Results: At 24 months, both groups showed significant improvement in periodontal outcomes ( p < 0.05). The test intervention was more effective than the control in reducing median BoP ( p = 0.033), GBI ( p = 0.023), the number of pockets ≥4 mm with BoP ( p = 0.018), 4–5 mm ( p = 0.048), 5–6 mm ( p = 0.011), and >6 mm ( p = 0.023). Among all follow‐up sessions, the reduced BoP was significantly negatively influenced by the number of median PPD ( p = 0.031), the number of pockets 4–5 mm ( p = 0.029), PPD 5–6 mm ( p = 0.036), smoking ( p = 0.039), and by the number of cigarettes/day ( p = 0.042) and positively by test treatment ( p = 0.033). Conclusion: SPC that included subgingival instrumentation yielded better results than the control to reduce BoP at 24‐month follow‐up. Smoking and deep pockets negatively influenced the BoP reduction in patients who underwent SPC. Plain Language Summary: Supportive periodontal care (SPC) is a series of individualized, site‐specific treatments aimed at preventing periodontitis recurrence/progression after successful completion of active periodontal therapy. SPC approaches performed by means of oral hygiene instruction with supra‐ and subgingival instrumentation and dental polishing (test group) compared to oral hygiene with supragingival instrumentation alone and dental polishing (control group) were both effective in reducing median periodontal outcomes, such as bleeding on probing (BoP), probing pocket depth (PPD), clinical attachment level (CAL), and full‐mouth plaque score (FMPS) after active periodontal treatment. However, the SPC approach that included subgingival instrumentation yielded better results compared to oral prophylaxis alone in reducing BoP, a parameter that was significantly influenced also by smoking, median PPD, a high number of sites with PPD 4–5 mm, 5–6 mm, and no sites >6 mm at 24‐month follow‐up.

7 May 2024 in Medicina
Verified
Journal Article
Open access
PDF file
AAAngela Angjelova
Angela Angjelova
EJElena Jovanova
Elena Jovanova
Alessandro PolizziAlessandro Polizzi
Alessandro Polizzi
Marco AnnunziataMarco Annunziata
Marco Annunziata
LLLudovica Laganà
Ludovica Laganà
Gaetano IsolaGaetano Isola
Gaetano Isola
The regeneration of periodontal bone defects continues to be an essential therapeutic concern in dental biomaterials. Numerous biomaterials have been utilized in this sector so far. However, the immune response and vascularity in defect regions may be disregarded when evaluating the effectiveness of biomaterials for bone repair. Among several regenerative treatments, the most recent technique of in situ tissue engineering stands out for its ability to replicate endogenous restorative processes by combining scaffold with particular growth factors. Regenerative medicine solutions that combine biomaterials/scaffolds, cells, and bioactive substances have attracted significant interest, particularly for bone repair and regeneration. Dental stem cells (DSCs) share the same progenitor and immunomodulatory properties as other types of MSCs, and because they are easily isolable, they are regarded as desirable therapeutic agents in regenerative dentistry. Recent research has demonstrated that DSCs sown on newly designed synthetic bio-material scaffolds preserve their proliferative capacity while exhibiting increased differentiation and immuno-suppressive capabilities. As researchers discovered how short peptide sequences modify the adhesion and proliferative capacities of scaffolds by activating or inhibiting conventional osteogenic pathways, the scaffolds became more effective at priming MSCs. In this review, the many components of tissue engineering applied to bone engineering will be examined, and the impact of biomaterials on periodontal regeneration and bone cellular biology/molecular genetics will be addressed and updated.

1 April 2026 in Periodontology 2000
Verified
Journal Article
Open access
Gaetano IsolaGaetano Isola
Gaetano Isola
Alessandro PolizziAlessandro Polizzi
Alessandro Polizzi
AAAngela Angjelova
Angela Angjelova
EJElena Jovanova
Elena Jovanova
Giuseppe PizzoGiuseppe Pizzo
Giuseppe Pizzo
Anton SculeanAnton Sculean
Anton Sculean
Aim: To evaluate the adjunctive effects of systemic antibiotics (SA) on clinical and microbiological outcomes in the treatment of peri‐implant diseases. Materials and Methods: A systematic review and meta‐analysis were conducted following PRISMA guidelines and registered on PROSPERO (CRD420251059056). Randomized and non‐randomized clinical trials evaluating SA as adjuncts to non‐surgical treatment of peri‐implant mucositis (PM) and to non‐surgical or surgical therapy of peri‐implantitis (PI) were included. Rob2 and MINORS tools were used to assess the risk of bias of included articles. Results: Eighteen studies were included in the qualitative analysis, of which only nine randomized clinical trials met the criteria for quantitative analysis. For PM treatment, SA did not significantly affect any assessed clinical outcomes (p>0.05). For PI treatment, the meta‐analysis showed that, in both non‐surgical and surgical PI treatment, adjunctive SA resulted in a significant bleeding on probing reduction at 12 months (p=0.007) and a significant probing pocket depth reduction at 12 months (p=0.004). However, no significant improvements in marginal bone level (MBL) were observed. For antimicrobial outcomes, only 2 studies reported significant effects of metronidazole as an adjunct to treatment on reductions in P. gingivalis and T. forsythia up to 12 months. Conclusions: SA do not provide additional clinical or microbiological benefits in the treatment of PM. In PI, adjunctive systemic antibiotics may offer only limited improvements in selected clinical outcomes and specific peri‐implant pathogens for up to 12 months, without consistent benefits on MBL. However, given the heterogeneity of the available evidence, further high‐quality, long‐term studies are needed.

28 October 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
AAAngela Angjelova
Angela Angjelova
EJElena Jovanova
Elena Jovanova
Alessandro PolizziAlessandro Polizzi
Alessandro Polizzi
SSSimona Santonocito
Simona Santonocito
Antonino Lo GiudiceAntonino Lo Giudice
Antonino Lo Giudice
Gaetano IsolaGaetano Isola
Gaetano Isola
Oral leukoplakia is a predominantly white lesion of the oral mucosa that cannot be classified as any other definable lesion with the risk of progressing into malignancy. Despite the advancements in conventional therapy, the rates of malignant transformation remain notably high, affecting 4.11% of adults, due to the difficulty of accurate diagnosis and indistinct treatment. Photodynamic therapy (PDT), being a minimally invasive surgical intervention, employs a variety of factors, including light, nano-photosensitizers (PSs) and oxygen in the management of precancerous lesions. PDT faces limitations in administering photosensitizers (PSs) because of their low water solubility. However, these challenges could be effectively resolved through the incorporation of PSs in nanostructured drug delivery systems, such as gold nanoparticles, micelles, liposomes, metal nanoparticles, dendrimers and quantum dots. This review will give an overview of the different innovative PS approaches in the management of premalignant lesions, highlighting the most recent advancements. From a clinical perspective, it is expected that nanotechnology will overcome barriers faced by traditional therapeutics and will address critical gaps in clinical cancer care.

8 August 2025 in Antibiotics
Verified
Journal Article
Open access
PDF file
AAAngela Angjelova
Angela Angjelova
EJElena Jovanova
Elena Jovanova
Alessandro PolizziAlessandro Polizzi
Alessandro Polizzi
Rosalia Maria LeonardiRosalia Maria Leonardi
Rosalia Maria Leonardi
Gaetano IsolaGaetano Isola
Gaetano Isola
Background: Oral antiseptic formulations are widely used as adjuncts in oral hygiene to reduce pathogenic microorganisms and prevent oral diseases. While these agents are effective in controlling biofilm, their broader effects may disrupt the oral microbiota’s balance, potentially contributing to systemic health implications. The complex relationship between antiseptic use, microbial composition, and systemic outcomes remains insufficiently mapped. Objective: This scoping review aimed to explore and map the current evidence regarding the impact of antiseptic formulations on oral microbiota composition and to examine their potential associations with systemic diseases. Methods: A comprehensive literature search was performed using PubMed, Scopus, and Web of Science up to June 2025. Studies were included if they investigated antiseptic formulations commonly used in oral healthcare—such as chlorhexidine, essential oils, and cetylpyridinium chloride—and reported effects on oral microbiota and/or systemic health. Eligible study types included human clinical trials, observational studies, in vitro, and animal studies. Two reviewers independently screened and selected studies, with disagreements resolved by consensus. Data extraction focused on study design, antiseptic agents, microbial outcomes, and systemic implications. A total of 12 studies were included and charted. Results: The included studies demonstrated that oral antiseptics effectively reduce pathogenic microorganisms and improve clinical outcomes in oral diseases such as gingivitis and periodontitis. However, several studies also reported alterations in commensal microbial communities, suggesting a potential for dysbiosis. Some studies indicated possible links between antiseptic-induced microbial changes and systemic conditions, including cardiovascular and respiratory diseases. Conclusions: The evidence highlights a dual effect of antiseptic formulations: while beneficial in controlling oral pathogens, they may disrupt microbial homeostasis with possible systemic consequences. Further research is needed to evaluate long-term effects and develop targeted, microbiota-preserving oral hygiene strategies.